HomePTKFF • OTCMKTS
Kalbe Farma Tbk PT
$0.095
Nov 22, 12:20:08 AM GMT-5 · USD · OTCMKTS · Disclaimer
StockUS listed security
Previous close
$0.095
Year range
$0.087 - $0.11
Market cap
68.91T IDR
Avg Volume
62.00
P/E ratio
-
Dividend yield
-
Primary exchange
IDX
Market news
Financials
Income Statement
Revenue
Net income
(IDR)Sep 2024Y/Y change
Revenue
7.91T7.16%
Operating expense
2.29T15.55%
Net income
573.28B6.97%
Net profit margin
7.25-0.14%
Earnings per share
12.417.73%
EBITDA
874.81B1.14%
Effective tax rate
23.01%
Total assets
Total liabilities
(IDR)Sep 2024Y/Y change
Cash and short-term investments
4.32T45.45%
Total assets
28.75T5.78%
Total liabilities
4.84T0.67%
Total equity
23.91T
Shares outstanding
46.15B
Price to book
0.00
Return on assets
6.15%
Return on capital
7.16%
Net change in cash
(IDR)Sep 2024Y/Y change
Net income
573.28B6.97%
Cash from operations
1.16T22.56%
Cash from investing
-176.64B33.78%
Cash from financing
-421.11B51.91%
Net change in cash
481.86B1,978.42%
Free cash flow
752.00B13.84%
About
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise. The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, distribution arm that reaches over 1 million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient. Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Prenagen, Extra Joss and Fitbar. Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. Wikipedia
Founded
Sep 10, 1966
Employees
12,924
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
Search
Clear search
Close search
Google apps
Main menu